PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights
News provided by
Share this article
Share this article
SANDUSKY, Ohio, May 6, 2021 /PRNewswire/ PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout Presentation scheduled for tomorrow, Friday, May 7, 2021, will feature the roles Alkame Holdings, Inc. (USOTC: ALKM) and North American Cannabis Holdings, Inc. (USOTC: USMJ) play in the CBD Nutraceutical Rollout.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT .
PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.